Pharmafile Logo
Pharmafocus logo
Advanced Search

Biogen IDEC

Showing 15 posts of 20 posts found.

Biogen to build billion-dollar plant in Switzerland

July 7, 2015
Manufacturing and Production Alzherimer's disease, Biogen, Biogen IDEC, MS, Switzerland, manufacturing, multiple sclerosis

Biogen plans to open a $1 billion manufacturing facility in Switzerland, to help Europe deal with the future demand for …

News
Biogen image

Big pharma partners with government over $100m dementia fund

March 17, 2015
Research and Development, Sales and Marketing Alzheimer's, Biogen IDEC, GSK, J&J, JJ, Pfizer, government, jp morgan, lilly

Lilly, Pfizer, GSK, J&J and Biogen Idec are set to join a $100m Dementia Discovery Fund to boost research into …

News
Biogen image

Pharma is boosting pipelines to avoid patent cliff

February 11, 2015
Sales and Marketing Biogen IDEC, Moody's, dimethyl fumarate, lilly, pharma, pipelines, sofosbuvir, sovaldi, tecfidera

Pharmaceutical companies have improved their pipelines of new drugs over the last 18 months according to financial analysts Moody’s Investors …

News
Biogen Idec image

Biogen Idec buys Convergence

January 14, 2015
Sales and Marketing BG00010, Biogen IDEC, CNV1014802, Colombia University Medical Center, Convergence, Neublastin

Biogen Idec is to acquire independent UK-based Convergence Pharmaceuticals to strengthen its pipeline of drugs for pain management in a …

News
Biogen Idec image

Mixed results for Biogen’s MS drug

January 9, 2015
Sales and Marketing Anti-LINGO-1, BIIB033, Biogen IDEC, MS, multiple sclerosis, plegridy

An experimental drug from Biogen Idec for the treatment of multiple sclerosis (MS) has shown a mixed bag of results …

News
Bayer image

Bayer files haemophilia drug in EU

December 5, 2014
Sales and Marketing BAY 81-8973, Bayer, Biogen IDEC, EMA, elocta, haemophilia a, kogenate

Bayer has submitted a marketing authorisation application to the EMA for its haemophilia A therapy BAY 81-8973. The German firm’s …

News

Astellas teams up with Proteostasis against protein defects

November 4, 2014
Research and Development, Sales and Marketing Astellas, Biogen IDEC, Protein, Proteostasis, upr

Astellas has announced it will collaborate with Proteostasis Therapeutics to develop drugs for diseases caused by protein defects, using the …

News
richard_ransohr

Two neuroscientists join Biogen Idec

October 30, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen IDEC, richard ransohoff

Christopher Henderson and Richard Ransohoff have joined Biogen Idec to lead the company’s neurology research and discovery efforts. Henderson joins …

Appointment
danos_biogen_idec

Biogen Idec hires senior vice president

October 2, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen IDEC, gene, olivier danos

US-based biotech firm Biogen Idec has hired Dr Olivier Danos to be the senior vice president of its gene therapy …

Appointment
donald_johns_biogen_idec

Biogen Idec hires from Novartis to head ALS

September 1, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen IDEC, Novartis, als, donald johns

Biogen Idec has appointed Dr Donald Johns as the vice president of its amyotrophic lateral sclerosis (ALS) innovation hub unit. …

Appointment
Biogen image

Alzheimer’s tie-up for Eisai and Biogen

March 6, 2014
Research and Development, Sales and Marketing Alzheimer's, BAN2401, Biogen IDEC, E2609, Eisai

Eisai and Biogen Idec have joined forces to look for new Alzheimer’s treatments, developing and commercialising two of the Japanese …

News
Biogen Idec image

Biogen Idec’s MS drug gets European approval

February 4, 2014
Manufacturing and Production, Sales and Marketing Aubagio, Biogen IDEC, EU, MS, gilenya, tecdifera

Biogen Idec’s oral multiple sclerosis drug Tecfidera has won approval in Europe as a first-line treatment for people with relapsing-remitting …

News
biogen idec image

Strong sales for Biogen Idec’s MS drug

October 29, 2013
Sales and Marketing Biogen IDEC, Q3, gilenya, tecfidera

Biogen Idec’s oral multiple sclerosis (MS) drug Tecfidera lived up to its blockbuster-in-waiting billing with third quarter sales that exceeded …

News
francesco_granata

Circassia appoints new chairman from Biogen Idec

September 26, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen IDEC, Circassia, granata

Speciality biopharma firm Circassia has appointed Dr Francesco Granata as its non-executive chairman.  Granata is executive in Residence at Warburg …

Appointment
biogen_idec_ten_cambridge_center

Amicus links with Biogen Idec

September 12, 2013
Research and Development, Sales and Marketing Amicus, Biogen IDEC, Parkinson's

Amicus Therapeutics and Biogen Idec have signed a collaboration agreement which will see them look for novel small molecules for …

News

Latest content

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024

Veru announces first patients enrolled in phase 2b trial for weight loss treatment

May 1, 2024

Bayer and Evotec to collaborate on precision cardiology

April 30, 2024

PeptiDream and Novartis extend peptide discovery collaboration

April 30, 2024

Pfizer’s Beqvez approved by FDA for haemophilia B treatment

April 29, 2024